Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.

Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.

Bibliographic Details
Main Authors:	Zinkernagel, MS, Hornby, S, Maclaren, R
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Myotonic dystrophy type 2
by: G. E. Rudenskaya, et al.
Published: (2017-02-01)

Cancer and Myotonic Dystrophy
by: Eleonora S. D’Ambrosio, et al.
Published: (2023-03-01)

Pattern retinal dystrophy in a case of myotonic dystrophy
by: Chahveer Singh Bindra, et al.
Published: (2023-01-01)

Myotonic dystrophy: diagnosis, management and new therapies.
by: Turner, C, et al.
Published: (2014)

Molecular genetics of myotonic dystrophy.
by: Barnes, P, et al.
Published: (1993)

The myotonic dystrophies: diagnosis and management.
by: Turner, C, et al.
Published: (2010)

Cardiac involvement in myotonic dystrophy
by: Koroush Khalighi, et al.
Published: (2015-02-01)

Ophthalmological findings in myotonic dystrophy
by: Maddalena De Bernardo, et al.

Cardiac Pathology in Myotonic Dystrophy Type 1
by: Mani S. Mahadevan, et al.
Published: (2021-11-01)

Targeting Myotonic Dystrophy Type 1 with Metformin
by: Mikel García-Puga, et al.
Published: (2022-03-01)

New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). The International Myotonic Dystrophy Consortium (IDMC).
by: Ashizawa, T, et al.
Published: (2000)

Hearing impairment in patients with myotonic dystrophy type 2
by: van Vliet, J, et al.
Published: (2018)

PPMO's as therapeutic modulators for myotonic dystrophy type 1
by: Holland, A, et al.
Published: (2018)

Myotonic dystrophy type 1: one case report
by: WU Xu⁃ling, et al.
Published: (2023-08-01)

Benefits of aerobic exercise in myotonic dystrophy type 1
by: Samuel J. Mackenzie, et al.
Published: (2022-05-01)

Alternative isoform regulation in myotonic dystrophy
by: Wang, Eric T. (Eric Tzy-shi)
Published: (2012)

Steinert’s Myotonic Dystrophy. Case Presentation
by: Rafael Lorenzo Comas Valdespino, et al.
Published: (2017-02-01)

Cellular Senescence and Aging in Myotonic Dystrophy
by: Yuhei Hasuike, et al.
Published: (2022-02-01)

Myotonic Dystrophies: A Genetic Overview
by: Payam Soltanzadeh
Published: (2022-02-01)

Disrupting the Molecular Pathway in Myotonic Dystrophy
by: Xiaomeng Xing, et al.
Published: (2021-12-01)

Epigenetics of Myotonic Dystrophies: A Minireview
by: Virginia Veronica Visconti, et al.
Published: (2021-11-01)

Congenital Myotonic Dystrophy in the Neonatal Period -
by: Barbora Červenková
Published: (2023-06-01)

Anesthesia for a Patient with Myotonic Dystrophy
by: Dilek Kalaycı, et al.
Published: (2016-09-01)

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
by: Thiéry De Serres-Bérard, et al.
Published: (2022-11-01)

Application of antisense conjugates for the treatment of myotonic dystrophy type 1
by: Stoodley, J, et al.
Published: (2023)

The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
by: Emma Koehorst, et al.
Published: (2020-12-01)

Senescence plays a role in myotonic dystrophy type 1
by: Mikel García-Puga, et al.
Published: (2022-10-01)

Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1
by: Jessica Stoodley, et al.
Published: (2023-01-01)

A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
by: Ji-Hyun Choi, et al.
Published: (2018-09-01)

Commentary: Autoimmune diseases in patients with myotonic dystrophy type 2
by: Manon J. Damen, et al.
Published: (2022-11-01)

Structural white matter networks in myotonic dystrophy type 1
by: Maud van Dorst, et al.
Published: (2019-01-01)

Peptide-conjugated PMOs for the treatment of myotonic dystrophy
by: Stoodley, J, et al.
Published: (2022)

Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics
by: Lubov Timchenko
Published: (2022-10-01)

Development of Therapeutic Approaches for Myotonic Dystrophies Type 1 and Type 2
by: Lubov Timchenko
Published: (2022-09-01)

Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing
by: Mariapaola Izzo, et al.
Published: (2022-04-01)

Small and large fiber neuropathy in adults with myotonic dystrophy type 1
by: Gro Solbakken, et al.
Published: (2024-03-01)

An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
by: Andrea López-Martínez, et al.
Published: (2020-09-01)

Molecular and Clinical Implications of Variant Repeats in Myotonic Dystrophy Type 1
by: Stojan Peric, et al.
Published: (2021-12-01)

Structural myocardial involvement in adult patients with type 1 myotonic dystrophy
by: Upinder K. Dhand, et al.
Published: (2013-03-01)

Increased functional connectivity of white-matter in myotonic dystrophy type 1
by: Jing Li, et al.
Published: (2022-08-01)